Generate a tailored SOP for Dr. Douglas Hixson. Improve your application with a focused, well-structured draft.
Douglas C. Hixson is a Professor Emeritus of Pathology and Laboratory Medicine and Medicine at Brown Medical School, where he directs the Molecular Carcinogenesis Laboratory at Rhode Island Hospital. With over 25 years of experience, he has conducted extensive basic research on Ig-like cell adhesion molecules in ductal progenitor cells and liver carcinogenesis. He has authored 80 peer-reviewed publications and book chapters and is a principal investigator on NIH RO1 grants, as well as the director of the Center of Biomedical Research Excellence (COBRE) at Rhode Island Hospital. His ongoing research focuses on identifying molecular events that turn normal cells into cancer cells, primarily through the study of adhesion proteins like CEACAM, which play a crucial role in cancer cell growth. His work also investigates hepatic progenitor cells and their associations with liver regeneration and hepatocarcinogenesis, contributing to a deeper understanding of cellular targets and molecular pathways in liver cancer.
Molecular Carcinogenesis Laboratory • Rhode Island Hospital
Leading research on the molecular mechanisms of liver cancer and regenerative medicine.
Brown Medical School • Providence, RI
Teaching both undergraduate and graduate level courses while leading research initiatives.
Department: Department of Economics